RAM
PRAX icon

Readystate Asset Management’s Praxis Precision Medicines PRAX Stock Holding History

Readystate Asset Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.53M Buy
+10,548
New +$3.34M 0.12% 137
2026
Q1 		– Sell
-36,792
Closed -$10.8M – 894
2025
Q4 		$10.8M Sell
36,792
-72,385
-66% -$13.5M 0.44% 56
2025
Q3 		$5.79M Buy
+109,177
New +$5.29M 0.25% 87

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Readystate Asset Management's PRAX Position: Q2 2026 in Review

Readystate Asset Management opened a new position in Praxis Precision Medicines (PRAX) in Q2 2026: 10,548 shares worth $3.53M. The stake represents 0.12% of the portfolio and ranks #137 among its holdings. This is a return to the name: Readystate Asset Management previously reported a position in PRAX as recently as Q4 2025.

Readystate Asset Management first reported a position in PRAX in Q3 2025 and has held it in 3 quarters since. The position peaked at $10.8M in Q4 2025. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Readystate Asset Management held 10,548 shares of Praxis Precision Medicines worth $3.53M as of Q2 2026.
  • Praxis Precision Medicines was a new Readystate Asset Management position in Q2 2026.
  • Praxis Precision Medicines made up 0.12% of Readystate Asset Management's portfolio in Q2 2026, its #137 holding.
  • Readystate Asset Management first reported a position in Praxis Precision Medicines in Q3 2025 and has held it in 3 quarters since.
  • Readystate Asset Management's Praxis Precision Medicines position peaked at $10.8M in Q4 2025.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Readystate Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.